<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pone.0230878.t001" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pone.0230878.t001</object-id>
 <label>Table 1</label>
 <caption>
  <title>Antiretroviral resistance of individuals in virological failure in the state of Maranhão (Northeast Brazil).</title>
 </caption>
 <alternatives>
  <graphic id="pone.0230878.t001g" xlink:href="pone.0230878.t001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="center" rowspan="1" colspan="1"/>
     <th align="center" colspan="6" rowspan="1">Resistance Mutation Frequency</th>
    </tr>
    <tr>
     <th align="center" rowspan="2" colspan="1">Antiretroviral Drug Types</th>
     <th align="center" rowspan="1" colspan="1">Total N = 633</th>
     <th align="center" rowspan="1" colspan="1">2008–2012
      <xref ref-type="table-fn" rid="t001fn001">
       <sup>1</sup>
      </xref> (N = 140)
     </th>
     <th align="center" rowspan="1" colspan="1">2013–2014 (N = 132)</th>
     <th align="center" rowspan="1" colspan="1">2015 (N = 98)</th>
     <th align="center" rowspan="1" colspan="1">2016 (N = 160)</th>
     <th align="center" rowspan="1" colspan="1">2017 (N = 103)</th>
    </tr>
    <tr>
     <th align="center" rowspan="1" colspan="1">n (%) (CI95%)</th>
     <th align="center" rowspan="1" colspan="1">n (%) (CI95%)</th>
     <th align="center" rowspan="1" colspan="1">n (%) (CI95%)</th>
     <th align="center" rowspan="1" colspan="1">n (%) (CI95%)</th>
     <th align="center" rowspan="1" colspan="1">n (%) (CI95%)</th>
     <th align="center" rowspan="1" colspan="1">n (%) (CI95%)</th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td align="left" rowspan="1" colspan="1">PI
      <xref ref-type="table-fn" rid="t001fn002">
       <sup>2</sup>
      </xref>
     </td>
     <td align="center" rowspan="1" colspan="1">118 (18.6) (15.8–21.9)</td>
     <td align="center" rowspan="1" colspan="1">28 (20) (14.2–27.4)</td>
     <td align="center" rowspan="1" colspan="1">30 (22.7) (16.4–36.6)</td>
     <td align="center" rowspan="1" colspan="1">17 (17.3) (11.1–26.0)</td>
     <td align="center" rowspan="1" colspan="1">25 (15.6) (10.8–22.0)</td>
     <td align="center" rowspan="1" colspan="1">18 (17.5) (11.3–25.9)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">NRTI/NNRTI</td>
     <td align="center" rowspan="1" colspan="1">463 (73.1) (69.6–76.4)</td>
     <td align="center" rowspan="1" colspan="1">101 (72.1) (64.2–78.9)</td>
     <td align="center" rowspan="1" colspan="1">93 (70.5) (62.2–77.6)</td>
     <td align="left" rowspan="1" colspan="1">71 (72.4 (62.9–80.3)</td>
     <td align="center" rowspan="1" colspan="1">134 (83.8) (77.3–88.7)</td>
     <td align="center" rowspan="1" colspan="1">64 (62.1) (52.5–70.9)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">NRTI
      <xref ref-type="table-fn" rid="t001fn003">
       <sup>3</sup>
      </xref>
     </td>
     <td align="center" rowspan="1" colspan="1">413 (65.2) (61.5–68.9)</td>
     <td align="center" rowspan="1" colspan="1">94 (67.1) (59.0–74.4)</td>
     <td align="center" rowspan="1" colspan="1">83 (62.9) (54.4–70.6)</td>
     <td align="center" rowspan="1" colspan="1">68 (69.4) (59.7–77.6)</td>
     <td align="center" rowspan="1" colspan="1">108 (67.5) (59.9–74.3)</td>
     <td align="center" rowspan="1" colspan="1">57 (55.3) (45.7–64.6)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">NNRTI
      <xref ref-type="table-fn" rid="t001fn004">
       <sup>4</sup>
      </xref>
     </td>
     <td align="center" rowspan="1" colspan="1">366 (57.8) (53.9–61.6)</td>
     <td align="center" rowspan="1" colspan="1">81 (57.9) (49.6–65.7)</td>
     <td align="center" rowspan="1" colspan="1">71 (53.8) (45.3–62.1)</td>
     <td align="center" rowspan="1" colspan="1">53 (54.1) (44.2–63.6)</td>
     <td align="center" rowspan="1" colspan="1">104 (65) (57.3–72.0)</td>
     <td align="center" rowspan="1" colspan="1">57 (55.3) (45.7–64.6)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Any resistance</td>
     <td align="center" rowspan="1" colspan="1">469 (74.1) (70.5–77.4)</td>
     <td align="center" rowspan="1" colspan="1">102 (72.9) (65–79.5)</td>
     <td align="center" rowspan="1" colspan="1">96 (72.7) (64.6–79.6)</td>
     <td align="center" rowspan="1" colspan="1">72 (73.5) (64.0–81.2)</td>
     <td align="center" rowspan="1" colspan="1">135 (84.4) (78.0–89.2)</td>
     <td align="center" rowspan="1" colspan="1">64 (62.1) (52.5–70.9)</td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="t001fn001">
   <p>
    <sup>1</sup> In this period, 2010 was excluded (missing data)
   </p>
  </fn>
  <fn id="t001fn002">
   <p>
    <sup>2</sup> PI: Protease Inhibitors
   </p>
  </fn>
  <fn id="t001fn003">
   <p>
    <sup>3</sup> NRTI: Nucleoside Analog Reverse Transcriptase Inhibitors
   </p>
  </fn>
  <fn id="t001fn004">
   <p>
    <sup>4</sup> NNRTI: Non-analogous Nucleoside Reverse Transcriptase Inhibitors.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
